{
    "title": "RSS Feed Title",
    "link": "https://example.com",
    "description": "RSS Feed Description",
    "lastBuildDate": "2025-04-13T11:06:00.745617",
    "items": [
        {
            "title": "India could benefit from free trade in long term: Mercedes-Benz India MD & CEO",
            "link": "https://www.moneycontrol.com/news/business/companies/india-could-benefit-from-free-trade-in-long-term-mercedes-benz-india-md-ceo-12992765.html",
            "description": "In FY25, the overall luxury car segment is estimated to be at over 51,500 units compared to about 49,800 units in FY24.",
            "pubDate": "2025-04-13T09:57:26.754215"
        },
        {
            "title": "Apple India produces $22 billion of iPhones in shift from China",
            "link": "https://www.moneycontrol.com/news/business/apple-india-produces-22-billion-of-iphones-in-shift-from-china-12992665.html",
            "description": "The ramp-up suggests the iPhone maker and its suppliers are accelerating a pivot to India from China, a process it began when harsh Covid lockdowns hurt production at Apple\u2019s largest plant.",
            "pubDate": "2025-04-13T09:57:26.754305"
        },
        {
            "title": "TCS CEO warns of tariff fallout on retail, travel, and auto sectors amid trade uncertainty",
            "link": "https://www.moneycontrol.com/news/business/companies/tcs-ceo-warns-of-tariff-fallout-on-retail-travel-and-auto-sectors-amid-trade-uncertainty-12992818.html",
            "description": "However, the banking and financial services sector, which accounts for nearly a third of TCS's revenue, remains largely unaffected by the trade tensions, according to Krithivasan.",
            "pubDate": "2025-04-13T11:05:59.675159"
        },
        {
            "title": "Aurobindo Pharma bags USFDA nod for generic Xarelto, eyes $447 million US market",
            "link": "https://www.moneycontrol.com/news/business/companies/aurobindo-pharma-bags-usfda-nod-for-generic-xarelto-eyes-447-million-us-market-12992812.html",
            "description": "In addition to the final approval for the 2.5mg dosage, Aurobindo has also secured tentative approvals from the USFDA for Rivaroxaban tablets in 10mg, 15mg, and 20mg strengths.",
            "pubDate": "2025-04-13T11:05:59.675263"
        }
    ]
}